OpenAI backs $252M seed for Merge Labs, a brain-tech startup
OpenAI backs $252M seed for Merge Labs, a brain-tech startup
OpenAI leads a $252M seed round for Merge Labs, a brain-computer interface startup using ultrasound to read and write brain signals, signaling a bold leap in neurotech.
Merge Labs has just stepped out of stealth with a hefty seed round, reportedly around $252 million, led by OpenAI alongside other backers. The big idea: use ultrasound to read from and write to the brain, a brain-computer interface that aims to connect human minds with machines in ways previously reserved for science fiction. The venture is tied to Sam Altman’s circle, reflecting how OpenAI-backed projects are diversifying into neurotech and cognitive interfaces.
Supporters say ultrasound-based interfaces could offer safer, noninvasive ways to monitor and influence neural activity, with potential applications spanning medical therapies for neurodegenerative diseases or paralysis, as well as enabling more direct control of devices through thought. But experts warn the road from concept to clinical reality is long, with rigorous safety testing, regulatory approvals, and ethical questions about consent and privacy.
Valuation for Merge Labs sits around $850 million, and the seed money signals a broader appetite among AI founders to back ambitious hardware-software hybrids that could someday blur lines between mind and machine. While the technology remains early-stage, observers say the funding boosts the startup ecosystem for neurotech and neuroscience-driven AI research, potentially accelerating breakthroughs if hurdles can be cleared.
Looking ahead, the coming years will show whether ultrasounds can reliably translate neural signals into actionable commands and whether safe, ethical deployment can keep pace with investor enthusiasm. For now, the announcement marks a notable moment in the convergence of AI and brain science, with Merge Labs at the center of a bold new frontier.
